The medical imaging technology company said the initiative by Healthcare UK, part of the Department for International Trade (DIT), would build on the success of trade delegations that have visited India over the last four years.
Innovation in healthcare delivery is a key priority for healthcare providers in India, as India's healthcare market is projected to grow to US$372bn by 2022, Feedback said.
The event offers Feedback the chance to interact with key stakeholders and influencers from the Indian healthcare industry, including high-profile speakers from reputed organisations on key issues/opportunities in the industry from both the UK and India. Along with other companies on the mission, Feedback will receive dedicated support from the DIT network.
"There are a number of potential opportunities for Bleepa within the large and growing Indian healthcare market such as with the newly announced National Digital Health Mission, which targets giving every Indian citizen a unique health ID and digitised health records,” said Tom Oakley, the chief executive officer of Feedback in a statement.
"Bleepa has the ability to support the hub and spoke hospital system in India. With a population of 1.38 billion people, access to centres of excellence in the four major cities is not possible for all, with both capacity and funding limiting access to top tier treatment. We believe that Bleepa can provide the vital digital link between these centres of excellence and regional or even mobile care units, enabling millions more patients to receive the high standards of care targeted in the National Digital Health Mission,” he added.
Bleepa is an encrypted medical messaging app that can be used on smartphones, tablets and desktops, allowing clinicians to communicate with other team members securely.
The app enables faster clinical decision making between team members, which will improve patient care.
"We believe that Bleepa's digital modular capabilities as a CE marked communications platform would make Bleepa an attractive option for the Indian market. We look forward to scoping the opportunities available with the support of Healthcare UK and DIT," Oakley concluded.